Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease

A García-Blanco, M Baquero, M Vento, E Gil… - Journal of the …, 2017 - Elsevier
The high and increasing incidence of Alzheimer Disease (AD) worldwide is a major global
concern. Classical diagnosis is carried out in the dementia phase, often in the moderate …

Detection of inflammatory biomarkers in saliva and urine: potential in diagnosis, prevention, and treatment for chronic diseases

S Prasad, AK Tyagi… - Experimental Biology and …, 2016 - journals.sagepub.com
Inflammation is a part of the complex biological response of inflammatory cells to harmful
stimuli, such as pathogens, irritants, or damaged cells. This inflammation has been linked to …

[HTML][HTML] Urinary biomarkers and point-of-care urinalysis devices for early diagnosis and management of disease: a review

B Sequeira-Antunes, HA Ferreira - Biomedicines, 2023 - mdpi.com
Biosensing and microfluidics technologies are transforming diagnostic medicine by
accurately detecting biomolecules in biological samples. Urine is a promising biological fluid …

[HTML][HTML] Recent evidence in epigenomics and proteomics biomarkers for early and minimally invasive diagnosis of Alzheimer's and Parkinson's diseases

S Mayo, J Benito-León, C Peña-Bautista… - Current …, 2021 - ncbi.nlm.nih.gov
Background: Alzheimer's (AD) and Parkinson's diseases (PD) show deposits of improperly
folded modified proteins. Protein expression mechanisms are involved since the early …

Recent advances in research on Alzheimer's disease in China

Y Zhang, Y Li, L Ma - Journal of clinical neuroscience, 2020 - Elsevier
China has the largest number of individuals with dementia worldwide. Alzheimer's disease
(AD) is a growing global health issue that seriously threatens human health and quality of …

[HTML][HTML] Urinary metabolic phenotyping for Alzheimer's disease

N Kurbatova, M Garg, L Whiley, E Chekmeneva… - Scientific reports, 2020 - nature.com
Finding early disease markers using non-invasive and widely available methods is essential
to develop a successful therapy for Alzheimer's Disease. Few studies to date have examined …

[HTML][HTML] Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer's disease

Y Wang, Y Wang, J Zhu, Y Guan, F Xie… - Frontiers in Aging …, 2022 - frontiersin.org
The accumulation of endogenous formaldehyde is considered a pathogenic factor in
Alzheimer's Disease (AD). The purpose of this study was to investigate the relationship …

[HTML][HTML] Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42

SSA An, B Lee, JS Yu, K Lim, GJ Kim, R Lee… - Alzheimer's research & …, 2017 - Springer
Background A reliable blood-based assay is required to properly diagnose and monitor
Alzheimer's disease (AD). Many attempts have been made to develop such a diagnostic tool …

[HTML][HTML] Correlation between urine formaldehyde and cognitive abilities in the clinical spectrum of Alzheimer's disease

Y Wang, F Pan, F Xie, R He, Q Guo - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Urine-based formaldehyde has been reported to be a potential biomarker for Alzheimer's
disease (AD). However, there is a lack of research about the correlation between urine …

[HTML][HTML] Urinary biomarkers for neurodegenerative diseases

W Seol, H Kim, I Son - Experimental Neurobiology, 2020 - ncbi.nlm.nih.gov
Global incidence of neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD)
and Parkinson's disease (PD) is rapidly increasing, but the diagnosis of these diseases at …